Published in Med Clin (Barc) on June 10, 1995
Mitochondrial function in heart muscle from patients with idiopathic dilated cardiomyopathy. Cardiovasc Res (2000) 2.26
[Evaluation of the degree of adherence to the Mediterranean diet in patients with heart failure: DIME-EAHFE study]. An Sist Sanit Navar (2016) 2.05
RecA binding to a single double-stranded DNA molecule: a possible role of DNA conformational fluctuations. Proc Natl Acad Sci U S A (1998) 2.00
Acute pancreatitis and normoamylasemia. Not an uncommon combination. Ann Surg (1989) 1.94
Activities of new macrolides and fluoroquinolones against Mycobacterium ulcerans infection in mice. Antimicrob Agents Chemother (2001) 1.90
Activities of several antimicrobials against Mycobacterium ulcerans infection in mice. Antimicrob Agents Chemother (2000) 1.79
Tamoxifen and mammographic breast densities. Cancer Epidemiol Biomarkers Prev (2000) 1.72
The effect of acid suppression on sleep patterns and sleep-related gastro-oesophageal reflux. Aliment Pharmacol Ther (2005) 1.63
Polyarteritis nodosa confined to calf muscles. J Rheumatol (1992) 1.56
Type II topoisomerase mutations in ciprofloxacin-resistant strains of Pseudomonas aeruginosa. Antimicrob Agents Chemother (1999) 1.55
Reduced steady-state levels of mitochondrial RNA and increased mitochondrial DNA amount in human brain with aging. Brain Res Mol Brain Res (1997) 1.53
A 10-year prospective surveillance of Mycobacterium tuberculosis drug resistance in France 1995-2004. Eur Respir J (2007) 1.49
Cholinesterase inhibitor rivastigmine enhance the mitochondrial electron transport chain in lymphocytes of patients with Alzheimer's disease. J Neurol Sci (2003) 1.45
Combined stent implantation and endosaccular coil placement for treatment of experimental wide-necked aneurysms: a feasibility study in swine. AJNR Am J Neuroradiol (1994) 1.44
Multicentric evaluation of the MDR phenotype in leukemia. French Network of the Drug Resistance Intergroup, and Drug Resistance Network of Assistance Publique-Hôpitaux de Paris. Leukemia (1997) 1.41
Human immunodeficiency virus type 1 infection and myopathy: clinical relevance of zidovudine therapy. Ann Neurol (1993) 1.41
[Toxic myopathies: clinical, etiologic, and histologic study of 74 cases]. Med Clin (Barc) (1993) 1.40
[Visits to the emergency department due to ecstasy (MDMA) and amphetamine derivative consumption: Epidemiological, clinical and evolutional profile]. Rev Clin Esp (2010) 1.39
[Influenza A (H1N1): act two]. An Sist Sanit Navar (2011) 1.39
[Cardiopulmonary resuscitation in hospitalized patients in conventional units. Prospective study of 356 consecutive cases. Commission for Care of Cardiorespiratory Arrest]. Med Clin (Barc) (1997) 1.39
[Chronic fatigue syndrome: study of the clinical course of 28 cases]. Med Clin (Barc) (1997) 1.39
[Prospective study of patients who leave the emergency department before being seen by the physician]. Med Clin (Barc) (2000) 1.39
[Carnitine palmitoyltransferase deficiency as the cause of effort rhabdomyolysis]. Med Clin (Barc) (1998) 1.39
[Residents, duties and burnout syndrome]. Rev Clin Esp (2010) 1.38
[EAHFE (Epidemiology Acute Heart Failure Emergency) study: analysis of the patients with echocardiography performed prior to an emergency visit due to an episode of acute heart failure]. Rev Clin Esp (2011) 1.38
Occurrence of qnrA-positive clinical isolates in French teaching hospitals during 2002-2005. Clin Microbiol Infect (2006) 1.38
Molecular characterisation and origin of the Coffea arabica L. genome. Mol Gen Genet (1999) 1.33
Shifts in interleukin-4 and interferon-gamma production by T cells of patients with elevated serum IgE levels and the modulatory effects of these lymphokines on spontaneous IgE synthesis. J Allergy Clin Immunol (1991) 1.30
Production, characterization and control of a Neisseria meningitidis hexavalent class 1 outer membrane protein containing vesicle vaccine. Vaccine (1996) 1.27
Nationwide survey of extended-spectrum {beta}-lactamase-producing Enterobacteriaceae in the French community setting. J Antimicrob Chemother (2009) 1.25
Probing complex RNA structures by mechanical force. Eur Phys J E Soft Matter (2003) 1.22
Serum profiles of interleukin-6, interleukin-8, and interleukin-10 in patients with severe and mild acute pancreatitis. Pancreas (1999) 1.21
Conversion of irinotecan (CPT-11) to its active metabolite, 7-ethyl-10-hydroxycamptothecin (SN-38), by human liver carboxylesterase. Biochem Pharmacol (1996) 1.18
Sentinel lymph-node biopsy in breast cancer. Can J Surg (1999) 1.15
Metabolism of irinotecan (CPT-11) by human hepatic microsomes: participation of cytochrome P-450 3A and drug interactions. Cancer Res (1998) 1.15
Outcome of multi-drug-resistant tuberculosis in France: a nationwide case-control study. Am J Respir Crit Care Med (1999) 1.15
Pharmacokinetic and pharmacogenetic determinants of the activity and toxicity of irinotecan in metastatic colorectal cancer patients. Br J Cancer (2008) 1.13
Risk and aggressiveness of breast cancer in relation to plasma organochlorine concentrations. Cancer Epidemiol Biomarkers Prev (2000) 1.13
Experimental saccular aneurysms. II. A new model in swine. Neuroradiology (1994) 1.13
Biochemical parameters for the diagnosis of mitochondrial respiratory chain deficiency in humans, and their lack of age-related changes. Biochem J (1998) 1.12
Identification and properties of a major plasma metabolite of irinotecan (CPT-11) isolated from the plasma of patients. Cancer Res (1996) 1.11
Enhanced cytotoxicity of doxorubicin encapsulated in polyisohexylcyanoacrylate nanospheres against multidrug-resistant tumour cells in culture. Eur J Cancer (1994) 1.11
Ranavirus: past, present and future. Biol Lett (2011) 1.10
Microrheology of biopolymer-membrane complexes. Phys Rev Lett (2000) 1.09
Pharmacokinetics of adriamycin in patients with breast cancer: correlation between pharmacokinetic parameters and clinical short-term response. Eur J Cancer Clin Oncol (1982) 1.09
Mitochondrial cytochrome c oxidase inhibition during acute carbon monoxide poisoning. Pharmacol Toxicol (1998) 1.08
Pharmacokinetic interrelationships of irinotecan (CPT-11) and its three major plasma metabolites in patients enrolled in phase I/II trials. Clin Cancer Res (1997) 1.08
New anti-inflammatory N-pyridinyl(alkyl)phthalimides acting as tumour necrosis factor-alpha production inhibitors. Eur J Med Chem (2001) 1.07
Biosynthesis of an aminopiperidino metabolite of irinotecan [7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxycamptothecine] by human hepatic microsomes. Drug Metab Dispos (1998) 1.07
Autosomal recessive Wolfram syndrome associated with an 8.5-kb mtDNA single deletion. Am J Hum Genet (1996) 1.06
Identification and kinetics of a beta-glucuronide metabolite of SN-38 in human plasma after administration of the camptothecin derivative irinotecan. Cancer Chemother Pharmacol (1995) 1.06
Perioperative mortality and major cardio-pulmonary complications after lung surgery for non-small cell carcinoma. Eur J Cardiothorac Surg (1999) 1.06
An experimental arteriovenous malformation model in swine: anatomic basis and construction technique. AJNR Am J Neuroradiol (1994) 1.06
Diabetic foot ulcer and multidrug-resistant organisms: risk factors and impact. Diabet Med (2004) 1.06
Sex differences in presentation, management, and prognosis of patients with non-small cell lung carcinoma. J Thorac Cardiovasc Surg (2000) 1.05
Long-term weekly treatment of colorectal metastatic cancer with fluorouracil and leucovorin: results of a multicentric prospective trial of fluorouracil dosage optimization by pharmacokinetic monitoring in 152 patients. J Clin Oncol (1998) 1.05
Right ventricular overload and induced sustained ventricular tachycardia in operatively "repaired" tetralogy of Fallot. Am J Cardiol (1992) 1.04
Three-year survey of community-acquired methicillin-resistant Staphylococcus aureus producing Panton-Valentine leukocidin in a French university hospital. J Hosp Infect (2005) 1.04
B-cell development in the amphibian Xenopus. Immunol Rev (2000) 1.04
[Nitro-imidazoles--chemotherapeutic preparation and activity]. Arzneimittelforschung (1966) 1.03
Viscoelastic properties of actin-coated membranes. Phys Rev E Stat Nonlin Soft Matter Phys (2001) 1.03
[Familial sacro-coccygeal agenesis. Apropos of 6 cases in 2 families]. J Genet Hum (1974) 1.03
Long-term control of vancomycin-resistant Enterococcus faecium at the scale of a large multihospital institution: a seven-year experience. Euro Surveill (2012) 1.02
Technical feasibility and histopathologic studies of ethylene vinyl copolymer (EVAL) using a swine endovascular embolization model. AJNR Am J Neuroradiol (1994) 1.02
Smoking disturbs mitochondrial respiratory chain function and enhances lipid peroxidation on human circulating lymphocytes. Carcinogenesis (1999) 0.99
Absence of relationship between the level of electron transport chain activities and aging in human skeletal muscle. Biochem Biophys Res Commun (1996) 0.99
A surge of MDR and XDR tuberculosis in France among patients born in the Former Soviet Union. Euro Surveill (2013) 0.99
Gamma hydroxybutirate use for sexual assault. Emerg Med J (2004) 0.98
Pharmacodynamics of antibiotics in fibrin clots. J Antimicrob Chemother (1993) 0.98
RANTES stimulates Ca2+ mobilization and inositol trisphosphate (IP3) formation in cells transfected with G protein-coupled receptor 75. Br J Pharmacol (2006) 0.98
Pacemaker-related endocarditis. Report of 7 cases and review of the literature. Cardiology (1998) 0.97
Effects of general anaesthetic procedures on mitochondrial function of human skeletal muscle. Eur J Clin Pharmacol (1999) 0.97
DNA topoisomerase IIalpha expression and the response toprimary chemotherapy in breast cancer. Br J Cancer (2003) 0.96
Comparative cytotoxicity, DNA synthesis inhibition and drug incorporation of eight anthracyclines in a model of doxorubicin-sensitive and -resistant rat glioblastoma cells. Biochem Pharmacol (1989) 0.96
Mitochondrial involvement in antiretroviral therapy-related lipodystrophy. AIDS (2001) 0.96
Epidemiological investigation of Rendu-Osler disease in France: its geographical distribution and prevalence. Popul (1989) 0.95
Effects of the combination of camptothecin and doxorubicin or etoposide on rat glioma cells and camptothecin-resistant variants. Br J Cancer (2001) 0.95
Kinetics of the in vivo interconversion of the carboxylate and lactone forms of irinotecan (CPT-11) and of its metabolite SN-38 in patients. Cancer Res (1994) 0.95
Prophylaxis of gastrointestinal tract bleeding with magaldrate in patients admitted to a general hospital ward. Scand J Gastroenterol (1991) 0.95
Percutaneous transluminal coronary angioplasty for the treatment of variant angina. J Am Coll Cardiol (1985) 0.94
Increase in hospital-acquired bloodstream infections caused by extended spectrum beta-lactamase-producing Escherichia coli in a large French teaching hospital. Eur J Clin Microbiol Infect Dis (2008) 0.94
A nuclear defect in the 4p16 region predisposes to multiple mitochondrial DNA deletions in families with Wolfram syndrome. J Clin Invest (1996) 0.94
Surgical treatment of hydatid disease of the liver: a survey of 69 patients. Surgery (1988) 0.94
Molecular epidemiology of OXA-48-producing Klebsiella pneumoniae in France. Clin Microbiol Infect (2014) 0.93
Individual dose adaptation of anticancer drugs. Eur J Cancer (1994) 0.93
Is chronic non-specific low back pain chronic? Definitions of a problem and problems of a definition. Br J Gen Pract (1999) 0.93
More data about patients who leave emergency department without being seen by a doctor in European hospitals. Eur J Emerg Med (2000) 0.93
Molecular, cellular, and clinical aspects of the pharmacology of 20(S)camptothecin and its derivatives. Pharmacol Ther (1995) 0.93
Experimental models of bifurcation and terminal aneurysms: construction techniques in swine. AJNR Am J Neuroradiol (1994) 0.93
Elective hepatic resection in the elderly. Br J Surg (1992) 0.93